US OptionsDetailed Quotes
RIGL241220C33000
- 0.52
- 0.000.00%
15min DelayClose Dec 13 15:59 ET
0.00High0.00Low
0.52Open0.52Pre Close0 Volume7 Open Interest33.00Strike Price0.00Turnover389.62%IV77.26%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.52Extrinsic Value100Contract SizeAmericanOptions Type0.1463Delta0.0277Gamma36.37Leverage Ratio-0.1979Theta0.0003Rho5.32Eff Leverage0.0049Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet